SLC
LLY icon

Second Line Capital’s Eli Lilly LLY Stock Holding History

Second Line Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$447K Hold
478
– – 0.08% 95
2025
Q4 		$514K Buy
+478
New +$457K 0.11% 75
2024
Q4 		– Sell
-227
Closed -$201K – 140
2024
Q3 		$201K Buy
+227
New +$204K 0.05% 130

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Second Line Capital's LLY Position: Q1 2026 in Review

Second Line Capital held its Eli Lilly (LLY) position steady in Q1 2026 at 478 shares worth $447K. The position accounts for 0.08% of the portfolio, ranked #95.

Second Line Capital first reported a position in LLY in Q3 2024 and has held it in 3 quarters since. The position peaked at $514K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Second Line Capital held 478 shares of Eli Lilly worth $447K as of Q1 2026.
  • Second Line Capital left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.08% of Second Line Capital's portfolio in Q1 2026, its #95 holding.
  • Second Line Capital first reported a position in Eli Lilly in Q3 2024 and has held it in 3 quarters since.
  • Second Line Capital's Eli Lilly position peaked at $514K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Second Line Capital's 13F filing for Q1 2026, filed 15 May 2026.